Wikidata

(Q64071000)

English

Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis

clinical trial

In more languages

Statements

title
Study NOG112264, a Phase II Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis (English)
0 references
sponsor
GSK
0 references
country
Australia
0 references
Belgium
0 references
Canada
0 references
France
0 references
Germany
0 references
Italy
0 references
Japan
0 references
Netherlands
0 references
United Kingdom
0 references
start time
20 December 2012
0 references
end time
22 January 2015
0 references
number of participants
304
0 references
research site
GSK
0 references
minimum age
18 year
0 references
maximum age
80 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64071000&oldid=1857546905"